文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort.

作者信息

Maser R E, Usher D, Becker D J, Drash A L, Kuller L H, Orchard T J

机构信息

School of Life and Health Sciences, University of Delaware, Newark 19716.

出版信息

Diabetes Care. 1993 May;16(5):755-8. doi: 10.2337/diacare.16.5.755.


DOI:10.2337/diacare.16.5.755
PMID:8495616
Abstract

OBJECTIVE: To examine the potential associations of lipoprotein(a) and the complications of IDDM and their risk factors. RESEARCH DESIGN AND METHODS: This report focuses on 186 individuals with IDDM (mean age = 34 yr) participating in a 10-yr prospective study examining various complications. Lp(a) concentrations were evaluated for those with and without complications. RESULTS: A weak correlation was seen between Lp(a) and HbA1 (r = 0.16, P < 0.05). Lp(a) concentrations were not significantly different for those with or without proliferative retinopathy, overt nephropathy, peripheral vascular disease, or definite myocardial infarction or angina. However, an inverse association (P < 0.05) was seen with distal symmetric polyneuropathy. These results were also confirmed by categorical analyses (i.e., Lp(a) levels < or = 30 vs. > 30 mg/dl). CONCLUSIONS: These results suggest that any association of Lp(a) concentration with IDDM complications is likely to be weak or nonexistent. However, prospective studies are needed before its full role can be determined.

摘要

相似文献

[1]
Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort.

Diabetes Care. 1993-5

[2]
Spontaneous whole blood platelet aggregation, hematological variables and complications in insulin-dependent diabetes mellitus: the Pittsburgh Epidemiology of Diabetes Complications Study.

J Diabetes Complications. 1992

[3]
Factors associated with avoidance of severe complications after 25 yr of IDDM. Pittsburgh Epidemiology of Diabetes Complications Study I.

Diabetes Care. 1990-7

[4]
Incidence of complications in insulin-dependent diabetes mellitus: a survival analysis.

Am J Epidemiol. 1996-3-1

[5]
Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study.

Diabetes Care. 2001-6

[6]
The influence of pregnancy on IDDM complications.

Diabetes Care. 1995-7

[7]
Lipoprotein(a) in diabetes mellitus.

Clin Chim Acta. 1993-1-31

[8]
Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.

Diab Vasc Dis Res. 2018-9

[9]
Serum lipoprotein (a) in type 1 diabetic children and adolescents: relationships with HbA1c and subclinical complications.

Eur J Pediatr. 1996-3

[10]
The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.

Diabetes. 1995-8

引用本文的文献

[1]
Lipoprotein (a) in the Development and Progression of Diabetic Retinopathy: A Systematic Review and Meta-Analysis.

Medicina (Kaunas). 2025-6-24

[2]
General health of patients with diabetic macular edema-The LIPSIA study.

PLoS One. 2021

[3]
Lipoprotein(a) and cardiovascular disease in diabetic patients.

Clin Lipidol. 2012-8

[4]
A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes.

Diabetologia. 2005-8

[5]
Serum lipoprotein (a) in type 1 diabetic children and adolescents: relationships with HbA1c and subclinical complications.

Eur J Pediatr. 1996-3

[6]
Serum lipoprotein(a) levels in adolescents and young adults with insulin-dependent diabetes mellitus.

Eur J Pediatr. 1996-11

[7]
Lipoprotein (a) and vascular disease in diabetic patients.

Diabetologia. 1995-6

[8]
Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial.

Diabetes. 1995-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索